OmniaBio was featured on Next Great Big Ideas Podcast (NGBiOnTheRoad) while at #BIO2025 in Boston! At the conference, we revealed our vision for autologous CAR-T manufacturing using the Intelligent Factory, and Jim Wilson and Dan Salvo discuss the impact of these developments within the biotech space in Canada. Learn more at https://lnkd.in/dqq9JpX9!
OmniaBio
Biotechnology Research
Hamilton, Ontario 22,274 followers
OmniaBio Inc. is bringing life-saving cell and gene therapies to patients around the world.
About us
OmniaBio is redefining the future of cell therapy manufacturing through its proprietary AI-powered Intelligent Factory™. Purpose-built to accelerate discoveries and industrialize production, the Intelligent Factory™ integrates artificial intelligence and automation across the entire manufacturing lifecycle. With a focus on autologous CAR-T and other advanced therapies, OmniaBio’s platform enables scalable, efficient, and high-fidelity production by embedding predictive analytics, robotic bioprocessing, and digital quality systems into a unified, closed-loop system. This approach not only enhances throughput and consistency but also positions OmniaBio as a next-generation CDMO partner for innovators seeking to bring life-saving therapies to patients faster.
- Website
-
www.omniabio.com
External link for OmniaBio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Hamilton, Ontario
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
Get directions
190 Longwood Rd S
Hamilton, Ontario L8P 0A6, CA
Employees at OmniaBio
-
Kevin Scannell
-
Valorie Tutt
Legal and Regulatory Leader within both Private and Public Sector | Negotiator | Governance | Policy | Business Partner | Healthcare | Procurement…
-
Olga Leonenko
Technical Writer / Compliance Associate @ OmniaBio | Documentation and Compliance Expertise
-
Michael Israels
CFO, CCRM
Updates
-
Here it is - our rhythm-driven sonic experience that we made in-house and debuted at #BIO2025 to unveil The Intelligent Factory: our vision of the future of CAR-T manufacturing. Sound on! 🔊 We're integrating AI and robotics into a historically manual process. The bottom line: - 50%+ cost savings - 40% labor reduction - 80% donor cell quality prediction - 4x throughput This is the beginning of a transformation to make CAR-T manufacturing faster, safer, more reliable, and accessible to patients that count on it. Learn more at https://lnkd.in/dqq9JpX9 #car-t #musicvideo #science
-
It was an honor to have our CEO, Mitchel Sivilotti, adding to the remarkable representation of Canadian biotechnology innovation at #bio2025. Thank you for having us at the Canadian Pavilion to share our vision for scaling CAR-T manufacturing!
Day 2 at the BIO International Convention was NEXT LEVEL! 🚀 Our team is seriously hyped by Ontario's (and especially HamOnt's!) commitment to life sciences innovation. The Canada Pavilion hosted some awesome talks around bringing transformative health innovations to market. So many cool insights! 💬Key highlights from the day: 💡 From the Invest Ontario Fund to Ontario Centre of Innovation (OCI)'s Life Sciences Innovation Fund, the province is putting serious capital behind its ambition to hit 85,000 life sciences employees by 2030. 💡 The Hospital for Sick Children (SickKids) Director of Partnerships, Ihor Boszko, shared compelling stats on their massive research spending ($300M+ annually) and focus on translational work, speeding up the path from discovery to real-world outcomes. 💡 Hamilton stepping up: Our own Mayor Andrea Horwath (City Of Hamilton) delivered a compelling message, positioning Hamilton as a city not just incubating talent, but scaling it. From McMaster University's nuclear reactor supplying global cancer treatment compounds to the expanded McMaster Innovation Park, Hamilton is ready to help life sciences companies grow. 💡 OmniaBio CEO Mitchel Sivilotti closed the session, highlighting Canada’s largest commercial-scale Cell & Gene Therapy (CGT) facility in Hamilton. With 160,000 sq ft of manufacturing infrastructure and 150+ client projects, OmniaBio is solving critical industry gaps in scalable, efficient biomanufacturing. 🧬With the Hamilton-Halton region at its core, Ontario's CGT ecosystem is seeing incredible growth. This evolution goes beyond local success, positioning our province as a global force in advanced bio-manufacturing. So proud to be representing our region here! #BIO2025 #HealthTech #Innovation #LifeSciences #BioTech #Ontario
-
-
-
-
-
+1
-
-
As we begin day 3 of #BIO2025, we invite you to booth #747 for a glimpse into the future of CAR-T manufacturing. Join Poornima Manavalan, Director of Business Development, and our team as we unveil the Intelligent Factory: a bold, immersive experience designed to revolutionize how we think about efficiency, sustainability, and smart connectivity. Watch our short film, explore interactive displays, and connect with us to discover how this innovation can help power your business forward.
-
The buzz is real—can you hear it? Or maybe you should *see* it. 🎧 Swing by booth #747 at BIO to watch The Rhythm of CAR-T Manufacturing, our audio-centric short film that’s making waves. Also – scan your badge for a chance to win a set of delicious noise-cancelling Bose headphones! #BIO2025
-
We’re proud to be part of a powerful conversation on the future of health at this year’s BIO International Convention. Join us this Tuesday at 10:00 a.m. at Booth 1038 (Canada Pavilion Stage) for Shaping the Future of Health: Ontario’s Ecosystem in Action. Our President & CEO, Mitchel Sivilotti, will be speaking alongside leaders from The Hospital for Sick Children, the City Of Hamilton, and the Ontario Government | Gouvernement de l’Ontario to explore how Ontario’s life sciences ecosystem is scaling cell and gene therapy manufacturing to turn scientific breakthroughs into real-world impact. We hope to see you there! #BIO2025
-
-
Meet Jason Cervi, the new Chief Financial Officer here at OmniaBio. A seasoned financial executive with 20+ years of leadership in highly regulated industries including healthcare, medical devices, and aerospace & defense. From building the finance infrastructure for public companies to leading global process and technology transformations, Jason brings deep expertise in M&A, business integration, and operational excellence. A CPA with a passion for scaling agile teams and driving strategic growth, Jason is a catalyst for change and innovation. We're grateful to have you on board. Welcome to the team, Jason!
-